Jazz Pharmaceuticals JAZZ Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's compensation and benefits?
- Jazz Pharmaceuticals (JAZZ) reported compensation and benefits of $74.5M in Q1 2026.
- How has Jazz Pharmaceuticals's compensation and benefits changed year-over-year?
- Jazz Pharmaceuticals's compensation and benefits increased by 10.0% year-over-year, from $67.7M to $74.5M.
- What is the long-term trend for Jazz Pharmaceuticals's compensation and benefits?
- Over 2 years (2021 to 2025), Jazz Pharmaceuticals's compensation and benefits has grown at a 24.1% compound annual growth rate (CAGR), from $189.01M to $291.13M.
- What does compensation and benefits mean?
- Total cost of paying and providing benefits to all employees.
- How do you interpret compensation and benefits?
- An increase relative to revenue may suggest rising labor costs or aggressive hiring, while a decrease could indicate efficiency gains or cost-cutting measures.
- How does compensation and benefits compare across companies?
- A core operating expense line item for all service and R&D-heavy industries.